The Trump administration has been prodded to take strong action against fake diabetes medications that have become readily available to U.S. consumers.

The drugs, called “GLP-1” medications, were highlighted by the National Association of Attorneys General in February in a statement calling on the Food and Drug Administration to take action. “These medications,” wrote the attorneys general, “which are in high demand for weight loss and diabetes management, have become targets for bad actors seeking to profit from supply shortages and high costs.”

But the situation is getting worse, not better, according to Reps. Brad Knott, a Republican, and Deborah Ross, a Democrat, of North Carolina. The Hill reported they have jointly sent a letter to three Trump administration department leaders asking for a boost in enforcement.

Read more at Newsmax© 2025 Newsmax. All rights reserved.